Skip to main content

View full-text article in PMC

. 2003 Nov 15;9(11):2501–2504. doi: 10.3748/wjg.v9.i11.2501

Table 1.

Positive rates of H. pylori-IgG in patients with different peptic cancers

	n	*Anti-H. pylori* IgG**
	n	-	+ (%)
Normal group	310	165	145 (46.77)^a
Cancer group	374	144	230 (61.50)^a
Esophagus carcinoma	63	30	33 (52.38)^b
Gastric cancer	97	13	84 (86.60)^b
duodenal Carcinoma	101	17	84 (83.17)^b
Rectal cancer	42	23	19 (45.24)^b
Carcinoma of colon	35	17	18 (51.43)^b
Liver cancer	36	20	16 (44.44)^b

^a

P < 0.01, χ² = 14.8;

^b

P < 0.01, χ² = 58.69.

HHS Vulnerability Disclosure